| Ytd | 35.85% | |
| 1y | -11.61% |
| Open | 8.95 | Prev Close | 8.89 | Low | 8.82 | High | 8.99 | Mkt Cap | 137.14M |
| Vol | 813.00 | Avg Vol | 63.94K | EPS | -1.62 | P/E | -5.45 | Forward P/E | N/A |
| Beta | 2.31 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 7.47 | 200-d Avg | 6.32 | 1yr Est | 0.00 |
Alpha Cognition Inc. (ACOG) possesses the right combination of the two key ingredients for a likely
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG), a biopha
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG)
Alpha Cognition Inc. (ACOG) witnessed a jump in share price last session on above-average trading vo
Biotech stocks are consolidating after a breakout, with bullish insider Wall Street sentiment. AbCel
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha C
Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. Consider
Raymond James analyst Ryan Deschner initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Ou
Alpha Cognition Inc. (Nasdaq: ACOG) (âAlpha Cognitionâ, or the âCompanyâ), a biopharmaceutic
Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition", or the "Company"), a biophar
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha C
Alpha Cognition, Inc. (ACOG: NASDAQ) ("Alpha Cognition" or the "Company"), a biophar
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition, Inc. (ACOG: NASDAQ
Providers reported cognitive improvement in 92% of patients following initiation of ZUNVEYLProvider
Alpha Cognition Inc. (NASDAQ: ACOG) (âAlpha Cognitionâ, âACIâ, or the âCompanyâ), a biop
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG)
Maxim Group analyst Naz Rahman initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Buy rat
Alpha Cognition Inc. (ACOG) Q1 2026 Earnings Call Transcript
Alpha Cognition Inc. (ACOG) came out with a quarterly loss of $0.37 per share versus the Zacks Conse
Alpha Cognition NASDAQ: ACOG reported 40% sequential revenue growth in the first quarter of 2026, as
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (ACOG: NASDAQ)
Alpha Cognition Inc. (ACOG) possesses the right combination of the two key ingredients for a likely
VANCOUVER, B.C. & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition, Inc. (NASDAQ: ACOG
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha C
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG)